Corey Whitesides
Medical · Columbia, MONPI 1689019614
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $10,108 of the $15,492 with a category attached, or 65.2%. 30 manufacturers reported payments, led by Johnson & Johnson at 47.2% of the total. 2025 is the largest year on record at $7,472, more than ten times the $58 reported in 2021. Among medical clinicians in MO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 455 payments — averaging $34.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$7K
- AbbVie$2K
- Novartis$2K
- E.r. Squibb & Sons, L.L.C.$992
- Lilly USA, LLC$825
- Regeneron Healthcare Solutions, Inc.$644
- plus $2K from 24 others
What the payments were for
- Consulting fees$3,60023%
- Travel & lodging$1,1998%
- Food & beverage$10,10865%
- Education$5854%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 92 | $7,314 |
| AbbVie | 110 | $2,066 |
| Novartis | 74 | $1,580 |
| E.r. Squibb & Sons, L.L.C. | 34 | $992 |
| Lilly USA, LLC | 44 | $825 |
| Regeneron Healthcare Solutions, Inc. | 19 | $644 |
| UCB, Inc. | 11 | $375 |
| Sanofi | 8 | $260 |
| Pfizer | 11 | $237 |
| Sun Pharmaceutical Industries Inc. | 6 | $197 |
| LEO Pharma Inc. | 6 | $147 |
| Janssen Scientific Affairs, LLC | 2 | $122 |
| Amgen | 6 | $115 |
| Boehringer Ingelheim | 3 | $93 |
| Incyte Corporation | 5 | $91 |
| Kerecis Limited | 2 | $54 |
| Merz North America, Inc. | 2 | $44 |
| Convatec Inc. | 2 | $41 |
| Fresenius Kabi USA, LLC | 2 | $41 |
| Biofrontera Inc. | 3 | $39 |
| Vericel Corporation | 2 | $36 |
| Organon | 3 | $28 |
| ANI Pharmaceuticals, Inc. | 1 | $23 |
| Mallinckrodt Hospital Products Inc. | 1 | $20 |
| Botanix SB Inc | 1 | $20 |
| Verrica Pharmaceuticals Inc. | 1 | $19 |
| Galderma Laboratories, L.p. | 1 | $19 |
| Organogenesis Inc. | 1 | $17 |
| Dermavant Sciences, Inc. | 1 | $16 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$15,492 in reported general payments places this provider in the 95th percentile of 198 medical providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 81 | $2,903 |
| Ketoconazole | 101 | $1,458 |
| Metronidazole | 17 | $1,181 |
| Clindamycin Phosphate | 21 | $871 |
| Doxycycline Hyclate | 47 | $704 |
| Triamcinolone Acetonide | 87 | $506 |
| Fluconazole | 26 | $400 |
| Mupirocin | 43 | $378 |
| Minoxidil | 49 | $144 |
| Hydrocortisone | 16 | $119 |
| Hydroxychloroquine Sulfate | 14 | $110 |
| Hydroxyzine Hcl | 13 | $76 |
Paid to pharmacies, not to this prescriber.
Other medical in Columbia
- Brittany ReedColumbia$7K
- Mariah GannColumbia$4K
- Eric JohnsonColumbia$1K
- Melanie ChisamSpringfield$92K
- Emily JensenBowling Green$51K
- Sarah WilmsmeyerChesterfield$22K
- Amy MosmanSaint Louis$21K
- Dustin BartlettSpringfield$21K
- Alexa Fider-WhyteSaint Louis$18K
- Megan Isaacson-SchmidSaint Louis$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.